Research progress in moderately hypofractionated radiotherapy for cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
; (6): 184-188, 2024.
Article
de Zh
| WPRIM
| ID: wpr-1027489
Bibliothèque responsable:
WPRO
ABSTRACT
Radiotherapy is one of the important treatment modalities for malignant tumors. Conventional fractionation is the most commonly-used radiotherapy mode, but it has disadvantages such as long treatment time and low efficiency, etc. With the advancement of radiotherapy equipment and technology, moderately hypofractionated radiotherapy has become the standard treatment for tumors such as breast cancer and prostate cancer, etc. However, the efficacy and safety of moderately hypofractionated radiotherapy have not been fully confirmed in a wider range of tumors. In this article, the application, efficacy, and safety of moderately hypofractionated radiotherapy in malignant tumors were reviewed.
Texte intégral:
1
Base de données:
WPRIM
Langue:
Zh
Journal:
Chinese Journal of Radiation Oncology
Année:
2024
Type de document:
Article